Page last updated: 2024-09-04

resiquimod and sm360320

resiquimod has been researched along with sm360320 in 6 studies

Compound Research Comparison

Studies
(resiquimod)
Trials
(resiquimod)
Recent Studies (post-2010)
(resiquimod)
Studies
(sm360320)
Trials
(sm360320)
Recent Studies (post-2010) (sm360320)
465143181806

Protein Interaction Comparison

ProteinTaxonomyresiquimod (IC50)sm360320 (IC50)
7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)2.809

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Horscroft, N; Laxton, C; Myangar, N; Parkinson, T; Rodman, J; Thomas, A1
Filippov, DV; Khan, S; Melief, CJ; Ossendorp, F; Overkleeft, HS; van der Burg, SH; van der Heden van Noort, GJ; van der Marel, GA; Weterings, JJ1
Bonnert, R; Hashimoto, K; Isobe, Y; Kurimoto, A; McInally, T; Nakamura, T; Norimura, K; Ogita, H; Takaku, H; Wada, H1
Alwan, H; Bista, M; Breed, J; Davies, NL; Eckersley, K; Fillery, S; Foote, KM; Goodwin, L; Jones, DR; Käck, H; Kettle, JG; Lau, A; Nissink, JW; Read, J; Scott, JS; Taylor, B; Walker, G; Wissler, L; Wylot, M1
Bazin, HG; Bess, LS; Cybulski, V; Evans, JT; Johnson, DA; Li, Y; Livesay, MT; Miller, SM1
Cornella-Taracido, I; De Gregorio, E; Galli-Stampino, L; Harrington, E; Isome, Y; Jain, R; Mbow, ML; Nuti, S; Russo, C; Sammicheli, C; Soldaini, E; Tallarico, J; Tavarini, S; Valiante, NM1

Other Studies

6 other study(ies) available for resiquimod and sm360320

ArticleYear
Investigating Toll-like receptor agonists for potential to treat hepatitis C virus infection.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8

    Topics: Antiviral Agents; Cell Line, Tumor; Cytokines; Hepacivirus; Hepatitis C; Humans; Leukocytes, Mononuclear; Toll-Like Receptor 3; Toll-Like Receptor 7; Toll-Like Receptor 9; Toll-Like Receptors

2007
2-Azidoalkoxy-7-hydro-8-oxoadenine derivatives as TLR7 agonists inducing dendritic cell maturation.
    Bioorganic & medicinal chemistry letters, 2009, Apr-15, Volume: 19, Issue:8

    Topics: Adenine; Amines; Animals; Azides; Cell Differentiation; Dendritic Cells; Mice; Toll-Like Receptor 7

2009
Synthesis and biological evaluation of 8-oxoadenine derivatives as toll-like receptor 7 agonists introducing the antedrug concept.
    Journal of medicinal chemistry, 2010, Apr-08, Volume: 53, Issue:7

    Topics: Adenine; Animals; Carboxylic Acids; Cell Line; Drug Stability; Humans; Hypersensitivity; Immunotherapy; Inflammation; Interferons; Male; Rats; Toll-Like Receptor 7

2010
Potent and Selective Inhibitors of MTH1 Probe Its Role in Cancer Cell Survival.
    Journal of medicinal chemistry, 2016, Mar-24, Volume: 59, Issue:6

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Crystallography, X-Ray; DNA Repair Enzymes; Drug Discovery; Humans; Models, Molecular; Phosphoric Monoester Hydrolases; Rats; RNA, Small Interfering; Structure-Activity Relationship

2016
Optimization of 8-oxoadenines with toll-like-receptor 7 and 8 activity.
    Bioorganic & medicinal chemistry letters, 2020, 03-15, Volume: 30, Issue:6

    Topics: Adenine; Adjuvants, Immunologic; Cytokines; Humans; Leukocytes, Mononuclear; Quinolines; Structure-Activity Relationship; Toll-Like Receptor 7; Toll-Like Receptor 8

2020
Small molecule Toll-like receptor 7 agonists localize to the MHC class II loading compartment of human plasmacytoid dendritic cells.
    Blood, 2011, May-26, Volume: 117, Issue:21

    Topics: Adenine; Aminoquinolines; Antineoplastic Agents; Cells, Cultured; Dendritic Cells; Enzyme Inhibitors; Fluorescent Antibody Technique; Fluorescent Dyes; Genes, MHC Class II; Humans; Imidazoles; Imiquimod; Macrolides; Proton-Translocating ATPases; Quinolines; Toll-Like Receptor 7

2011